Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial

Table 5

Adverse events in the intervention and control groups.

Safety-evaluable patients	Control (), (%)	Intervention (), (%)
Serious adverse events	0	0
Epigastric pain	0	1 (3.12)
Abdominal pain	2 (6.24)	1 (3.12)
Constipation	2 (6.24)	0
Xerostomia	4 (12.5)	0
Dizziness	2 (6.25)	0
Total number of adverse events	10 (31.25)	2 (6.24)
Total number of subjects experiencing adverse events	6 (18.75)	2 (6.24)

includes all patients who received at least one dose of study medication. value = 0.12. Control: hyoscine; intervention: herbal medicine.